300 North Capital’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q2
Sell
-4,417
Closed -$1.85M 53
2015
Q1
$1.85M Buy
4,417
+49
+1% +$20.5K 0.41% 89
2014
Q4
$1.2M Buy
4,368
+1,633
+60% +$447K 0.28% 88
2014
Q3
$533K Hold
2,735
0.14% 96
2014
Q2
$670K Hold
2,735
0.17% 85
2014
Q1
$725K Buy
2,735
+146
+6% +$38.7K 0.19% 85
2013
Q4
$940K Sell
2,589
-200
-7% -$72.6K 0.26% 80
2013
Q3
$1.48M Buy
+2,789
New +$1.48M 0.35% 93